DK1937245T3 - Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter - Google Patents
Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienterInfo
- Publication number
- DK1937245T3 DK1937245T3 DK06807318.8T DK06807318T DK1937245T3 DK 1937245 T3 DK1937245 T3 DK 1937245T3 DK 06807318 T DK06807318 T DK 06807318T DK 1937245 T3 DK1937245 T3 DK 1937245T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- left ventricular
- composition
- ventricular hypertrophy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Finger-Pressure Massage (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Road Signs Or Road Markings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/250,634 US20070087975A1 (en) | 2005-10-17 | 2005-10-17 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| PCT/EP2006/067465 WO2007045639A1 (en) | 2005-10-17 | 2006-10-16 | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1937245T3 true DK1937245T3 (da) | 2011-08-08 |
Family
ID=37661169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06807318.8T DK1937245T3 (da) | 2005-10-17 | 2006-10-16 | Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20070087975A1 (da) |
| EP (1) | EP1937245B1 (da) |
| JP (1) | JP5106403B2 (da) |
| AT (1) | ATE506946T1 (da) |
| CY (1) | CY1112144T1 (da) |
| DE (1) | DE602006021594D1 (da) |
| DK (1) | DK1937245T3 (da) |
| ES (1) | ES2364189T3 (da) |
| PL (1) | PL1937245T3 (da) |
| PT (1) | PT1937245E (da) |
| SI (1) | SI1937245T1 (da) |
| WO (1) | WO2007045639A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101209975B (zh) * | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1156741B (it) * | 1978-05-15 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi |
| IT1156852B (it) * | 1978-07-10 | 1987-02-04 | Sigma Tau Ind Farmaceuti | Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni |
| US4434816A (en) * | 1978-10-30 | 1984-03-06 | Giovanni Bernard A Di | Service line interior by-pass fitting |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
| IT1277147B1 (it) * | 1995-01-20 | 1997-11-04 | Sigma Tau Ind Farmaceuti | Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi. |
| IT1290801B1 (it) * | 1996-07-05 | 1998-12-11 | Mendes Srl | Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili |
| IT1294227B1 (it) * | 1997-08-01 | 1999-03-24 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione |
| DK1220670T3 (da) * | 1999-10-11 | 2006-12-18 | Sigma Tau Ind Farmaceuti | Anvendelse af L-carnitin og dets alkanoylderivater som osmotiske stoffer i oplösninger til medicinsk anvendelse |
| FR2846886A1 (fr) * | 2002-11-08 | 2004-05-14 | Merck Sante Sas | Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses |
-
2005
- 2005-10-17 US US11/250,634 patent/US20070087975A1/en not_active Abandoned
-
2006
- 2006-10-16 DE DE602006021594T patent/DE602006021594D1/de active Active
- 2006-10-16 EP EP06807318A patent/EP1937245B1/en not_active Not-in-force
- 2006-10-16 ES ES06807318T patent/ES2364189T3/es active Active
- 2006-10-16 JP JP2008536039A patent/JP5106403B2/ja not_active Expired - Fee Related
- 2006-10-16 AT AT06807318T patent/ATE506946T1/de active
- 2006-10-16 PT PT06807318T patent/PT1937245E/pt unknown
- 2006-10-16 SI SI200631051T patent/SI1937245T1/sl unknown
- 2006-10-16 WO PCT/EP2006/067465 patent/WO2007045639A1/en active Application Filing
- 2006-10-16 PL PL06807318T patent/PL1937245T3/pl unknown
- 2006-10-16 US US12/066,032 patent/US20080234373A1/en not_active Abandoned
- 2006-10-16 DK DK06807318.8T patent/DK1937245T3/da active
-
2011
- 2011-07-13 CY CY20111100677T patent/CY1112144T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1937245A1 (en) | 2008-07-02 |
| WO2007045639A1 (en) | 2007-04-26 |
| DE602006021594D1 (de) | 2011-06-09 |
| US20070087975A1 (en) | 2007-04-19 |
| US20080234373A1 (en) | 2008-09-25 |
| SI1937245T1 (sl) | 2011-11-30 |
| JP2009511619A (ja) | 2009-03-19 |
| ATE506946T1 (de) | 2011-05-15 |
| EP1937245B1 (en) | 2011-04-27 |
| JP5106403B2 (ja) | 2012-12-26 |
| ES2364189T3 (es) | 2011-08-26 |
| PL1937245T3 (pl) | 2011-09-30 |
| CY1112144T1 (el) | 2015-11-04 |
| PT1937245E (pt) | 2011-07-06 |
| WO2007045639A8 (en) | 2007-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
| EA200802184A1 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| BRPI0815577A2 (pt) | Peptídeo foxm1 e agente medicinal compreendendo o mesmo. | |
| BRPI0615157A2 (pt) | composto, composição farmacêutica, métodos para inibir a replicação viral em um paciente humano, e para tratar uma infecção viral em um paciente humano, e, uso de um composto | |
| BRPI0607198A2 (pt) | composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica | |
| DE602007004615D1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| BRPI0911203A2 (pt) | peptídeo ou derivado de peptídeo, composição farmacêutica, uso de um peptídeo ou derivado de peptídeo, métodos para tratar um paciente tendo uma deficiencia e para preparar o peptídeo ou derivado de peptídeo. | |
| RS53056B (en) | PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES | |
| PL1909843T3 (pl) | Przeciwnowotworowe biokoniugaty kwasu hialuronowego lub jego pochodne otrzymane przez pośrednie sprzęganie chemiczne i ich zastosowanie w dziedzinie farmacji | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| DK1771155T3 (da) | Fremgangsmåde og sammensætning til behandling af rhinitis | |
| CY1112184T1 (el) | Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii | |
| EP1848418A4 (en) | USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS | |
| CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
| DE602006005640D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
| DK1869185T3 (da) | Konjugat med P21-protein til kræftbehandling | |
| DE60318327D1 (de) | Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe | |
| DK1937245T3 (da) | Sammensætning til forebyggelse og behandling af venstre-ventrikulær hypertrofi hos dialysepatienter | |
| DK2193789T3 (da) | Anvendelse af 3,5-dihydroxytoluen eller derivater deraf i fremstillingen af medicin og funktionelle fødevarer til behandling eller forebyggelse af depression | |
| ATE550019T1 (de) | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs | |
| DK1894557T3 (da) | Flydende sammensætning til behandling og/eller forebyggelse af forskellige metaboliske knoglesygdomme, anvendelse heraf og fremgangsmåde til fremstilling heraf | |
| DE602005011029D1 (de) | Therapeutisches mittel zur behandlung von plasmazellneoplasien |